Association between galectin-3 and hepatosteatosis in a community-based cross-sectional study.

ABSTRACT: Hepatosteatosis is a common condition that can lead to cirrhosis and liver cancer. Galectin-3 (GAL-3) has been implicated in liver fibrosis and inflammation. The purpose of this study was to investigate the association between GAL-3 and hepatosteatosis. This study is a retrospective secondary analysis of data from a community health screening program. A total of 766 participants were included in the final analysis. Hepatosteatosis was diagnosed using ultrasonography, and GAL-3 levels were measured using enzyme-linked immunosorbent assay. Logistic regression analysis was used to examine the association between GAL-3 levels and the presence of hepatosteatosis, adjusting for age, sex, and other potential confounding factors. The prevalence of moderate-to-severe hepatosteatosis in the study po

SUBMITTER: Lin MS 

PROVIDER: S-EPMC11608448 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature